Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06477406 · ClinicalTrials.gov registry record · Phase 2

Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis

A Phase 2 study of Endometriosis, sponsored by Mclean Hospital.

Recruiting
Registry status
Phase 2
Development phase
30
Enrollment target
1
Study location

NCT06477406 is a Phase 2 study of Endometriosis that is actively recruiting participants, run by Mclean Hospital. The registered enrollment target is 30 participants, below the 264-participant average among 48 other Endometriosis trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06477406, a Phase 2 study of Endometriosis, is actively recruiting participants, sponsored by Mclean Hospital.

RECRUITING
Registry status
Phase 2
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Despite the proliferation of cannabis and cannabinoid products in recent years, little research has been done to determine the impact of these products on womens health conditions, including endometriosis. This study is designed to assess the impact of a custom-formulated, hemp-derived, full-spectrum, high-CBD product vs. placebo on clinical symptoms and biomarkers over the course of 12 weeks of treatment in patients with endometriosis. This project will provide information that does not currently exist on the potential efficacy of a cannabinoid-based sublingual product for endometriosis.

Conditions Studied

Endometriosis

Interventions

  • DRUG Placebo
  • DRUG Cannabidiol

Study Locations (1)

Massachusetts

  • McLean Hospital - Belmont

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-02-27
Est. Completion 2026-06
Phase Phase 2

Sponsor

Mclean Hospital

140 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06477406

The ClinicalTrials.gov registry entry for NCT06477406 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 264-participant average among 48 other Endometriosis trials with a reported enrollment target (89% lower). The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Endometriosis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06477406 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06477406 about?

NCT06477406 is a clinical study titled "Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis". Despite the proliferation of cannabis and cannabinoid products in recent years, little research has been done to determine the impact of these products on womens health conditions, including endometriosis. This study is designed to assess the impact of a custom-formulated, hemp-derived, full-spectru...

What is the current status of trial NCT06477406?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2024-02-27. Estimated completion is 2026-06.

What conditions does trial NCT06477406 study?

This clinical trial studies the following conditions: Endometriosis.

What interventions are being tested in trial NCT06477406?

The interventions under investigation include: Placebo (DRUG), Cannabidiol (DRUG).

Who is sponsoring clinical trial NCT06477406?

This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06477406 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Endometriosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Endometriosis

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.